
FTC eyes resuming insulin lawsuit against drug middlemen
By Jody Godoy (Reuters) -The U.S. Federal Trade Commission's lawsuit against pharmacy benefit managers (PBMs) over insulin pricing practices will likely move forward again after being paused amid President Donald Trump's firing of the agency's …